List Price Quantity
C12CA.1
Please inquire
Available for Bulk Order Bulk Quote
  • BABY RABBIT COMPLEMENT
  • Product Code
    C12CA.1
  • Description
    BABY RABBIT COMPLEMENT
  • Product Type
    Serum & Cells
  • Format
    Serum
  • Applications
    FN*, IY
  • Pack Size
    1 ml
Product Summary
Additional Formats
Related Reagents
More Images
Application Notes
References
More Information

BABY RABBIT COMPLEMENT Product Summary

Specificity

This rabbit serum is intended for use as a source of rabbit complement for cytotoxicity studies.

Product Form

Baby rabbit serum - lyophilised

Preservative Stabilisers

None present.

Reconstitution

Reconstitute with 1 ml ice cold distilled water

BABY RABBIT COMPLEMENT Additional Formats

BABY RABBIT COMPLEMENT Related Reagents

BABY RABBIT COMPLEMENT More Images

BABY RABBIT COMPLEMENT Application Notes

Application

This product has been reported to work in the following applications. This information is derived from testing within our laboratories, peer-reviewed publications or personal communications from the originators. Please refer to references indicated for further information.
Application NameYesNoNot DeterminedSuggested Dilution
Functional Assays(1)
Immunoassay
(1)
This product is not sold as sterile but can be sterilized by filtration if necessary. It is preferable to dilute the complement to a final working concentration before filtration in order to minimize loss of volume.
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.

BABY RABBIT COMPLEMENT References

References

1. Council of Europe. (1983) Essential aspects of tissue typing: Preparation, use, storage of reagents and standardisation of complement.
European Health Committee, Strasbourg, ISBN 92-871.224-4.
2. Edited by J.G.Ray. (1979) NIAID Manual of tissue typing techniques .
Publication No. NIH-80-545.
3. Anderson. L.D. Jr, et al. (1999) Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogenic bone marrow donors with a recipient-derived tumor cell vaccine.
Cancer Res. 59: 1525-1530.
4. Mason. J. et al. (2002) Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury.
Circ.Res. 91: 969-703.
5. Lidington. E. et al. (2000) Induction of decay-accelerating factor by thrombin through a protease-activated receptor 1 and protein kinase C-dependent pathway protects vascular endothelial cells from complement mediated injury.
Blood. 96: 2784-2972.
6. De Clerq. L. et al. (1997) An anti-adipocyte monoclonal antibody is cytotoxic to porcine preadipocytes in vitro and depresses the development of pig adipose tissue.
J.Anim. Sci. 75: 1791-1797.
7. Hung, M.C. et al. (2011) The Neisseria meningitidis Macrophage Infectivity Potentiator Protein Induces Cross-Strain Serum Bactericidal Activity and Is a Potential Serogroup B Vaccine Candidate.
Infect Immun. 79: 3784-91.
8. Lee, S.J. et al. (2012) Identification of a common immune signature in murine and human systemic Salmonellosis.
Proc Natl Acad Sci U S A. Feb 13. [Epub ahead of print]

BABY RABBIT COMPLEMENT More Information

Storage

Prior to reconstitution store at +4oC. Following reconstitution store at +4oC for 1 hour or aliquot and store at -70oC for longer.

This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the product. Should this product contain a precipitate we recommend microcentrifugation before use.

Shelf Life

6 months from the date of despatch.

Health And Safety Information

Material Safety Datasheet Documentation #10288 available at:
http://www.abdserotec.com/uploads/MSDS/10288.pdf

Events

Informa Biosimilars CongressPrague, Czech Republic May 22-23, 2012
Cedarlane ExpoToronto, Canada May 24, 2012